FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1948169006> ?p ?o ?g. }

• W1948169006 endingPage "519" @default.
• W1948169006 startingPage "513" @default.
• W1948169006 abstract "Argatroban, a direct thrombin inhibitor, is metabolized in vitro by CYP3A4/5 and therefore may be susceptible to clinically relevant CYP3A drug interactions. The effect of erythromycin, a potent CYP3A4/5 inhibitor, on the pharmacokinetics and pharmacodynamics of argatroban was evaluated in 14 healthy male volunteers in an open-label, crossover study with a 5-day washout between regimens. Argatroban 1 μg/kg/min was infused alone for 5 hours (regimen A) and again on day 6 of a 7-day oral regimen of 500 mg erythromycin four times daily (regimen B). Serial blood samples for the determination of activated partial thromboplastin time (aPTT) and argatroban concentrations were collected for up to 48 hours following infusion. Mean values for argatroban area under the concentration-time curves (AUC0 — inf), maximum concentration (Cmax), and half-life (t1/2) were similar between regimens. Mean aPTT values were not affected significantly by the concomitant administration of argatroban and erythromycin compared to argatroban alone. No serious adverse events or bleeding episodes occurred during the study. These results suggest that oxidative metabolism by CYP3A4/5 is unlikely to be an important in vivo elimination pathway for argatroban. Therefore, coadministration of CYP3A4/5 inhibitors should not require a modification in the dosage of argatroban." @default.
• W1948169006 created "2016-06-24" @default.
• W1948169006 creator A5026171352 @default.
• W1948169006 creator A5035112632 @default.
• W1948169006 creator A5036594562 @default.
• W1948169006 creator A5054853603 @default.
• W1948169006 creator A5056251841 @default.
• W1948169006 creator A5062055929 @default.
• W1948169006 creator A5079691701 @default.
• W1948169006 creator A5082142978 @default.
• W1948169006 date "1999-05-01" @default.
• W1948169006 modified "2023-10-17" @default.
• W1948169006 title "Assessment of the Potential Pharmacokinetic and Pharmacodynamic Interactions between Erythromycin and Argatroban" @default.
• W1948169006 cites W1926862327 @default.
• W1948169006 cites W1972280475 @default.
• W1948169006 cites W1976423008 @default.
• W1948169006 cites W1990652438 @default.
• W1948169006 cites W1997088191 @default.
• W1948169006 cites W201794629 @default.
• W1948169006 cites W2039927143 @default.
• W1948169006 cites W2054728105 @default.
• W1948169006 cites W2077646228 @default.
• W1948169006 cites W2081769864 @default.
• W1948169006 cites W2088949336 @default.
• W1948169006 cites W2104093795 @default.
• W1948169006 cites W2120917180 @default.
• W1948169006 cites W2410060119 @default.
• W1948169006 cites W4290987701 @default.
• W1948169006 doi "https://doi.org/10.1177/009127009903900512" @default.
• W1948169006 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10234600" @default.
• W1948169006 hasPublicationYear "1999" @default.
• W1948169006 type Work @default.
• W1948169006 sameAs 1948169006 @default.
• W1948169006 citedByCount "35" @default.
• W1948169006 countsByYear W19481690062012 @default.
• W1948169006 countsByYear W19481690062013 @default.
• W1948169006 countsByYear W19481690062014 @default.
• W1948169006 countsByYear W19481690062015 @default.
• W1948169006 countsByYear W19481690062016 @default.
• W1948169006 countsByYear W19481690062019 @default.
• W1948169006 countsByYear W19481690062021 @default.
• W1948169006 countsByYear W19481690062022 @default.
• W1948169006 crossrefType "journal-article" @default.
• W1948169006 hasAuthorship W1948169006A5026171352 @default.
• W1948169006 hasAuthorship W1948169006A5035112632 @default.
• W1948169006 hasAuthorship W1948169006A5036594562 @default.
• W1948169006 hasAuthorship W1948169006A5054853603 @default.
• W1948169006 hasAuthorship W1948169006A5056251841 @default.
• W1948169006 hasAuthorship W1948169006A5062055929 @default.
• W1948169006 hasAuthorship W1948169006A5079691701 @default.
• W1948169006 hasAuthorship W1948169006A5082142978 @default.
• W1948169006 hasConcept C109650736 @default.
• W1948169006 hasConcept C111113717 @default.
• W1948169006 hasConcept C112705442 @default.
• W1948169006 hasConcept C126322002 @default.
• W1948169006 hasConcept C2776301958 @default.
• W1948169006 hasConcept C2776710957 @default.
• W1948169006 hasConcept C2777292125 @default.
• W1948169006 hasConcept C2777628954 @default.
• W1948169006 hasConcept C2777849778 @default.
• W1948169006 hasConcept C2778261982 @default.
• W1948169006 hasConcept C2778810321 @default.
• W1948169006 hasConcept C2779161974 @default.
• W1948169006 hasConcept C2779612170 @default.
• W1948169006 hasConcept C2779837110 @default.
• W1948169006 hasConcept C2781413609 @default.
• W1948169006 hasConcept C42219234 @default.
• W1948169006 hasConcept C526171541 @default.
• W1948169006 hasConcept C62231903 @default.
• W1948169006 hasConcept C71924100 @default.
• W1948169006 hasConcept C89560881 @default.
• W1948169006 hasConcept C98274493 @default.
• W1948169006 hasConceptScore W1948169006C109650736 @default.
• W1948169006 hasConceptScore W1948169006C111113717 @default.
• W1948169006 hasConceptScore W1948169006C112705442 @default.
• W1948169006 hasConceptScore W1948169006C126322002 @default.
• W1948169006 hasConceptScore W1948169006C2776301958 @default.
• W1948169006 hasConceptScore W1948169006C2776710957 @default.
• W1948169006 hasConceptScore W1948169006C2777292125 @default.
• W1948169006 hasConceptScore W1948169006C2777628954 @default.
• W1948169006 hasConceptScore W1948169006C2777849778 @default.
• W1948169006 hasConceptScore W1948169006C2778261982 @default.
• W1948169006 hasConceptScore W1948169006C2778810321 @default.
• W1948169006 hasConceptScore W1948169006C2779161974 @default.
• W1948169006 hasConceptScore W1948169006C2779612170 @default.
• W1948169006 hasConceptScore W1948169006C2779837110 @default.
• W1948169006 hasConceptScore W1948169006C2781413609 @default.
• W1948169006 hasConceptScore W1948169006C42219234 @default.
• W1948169006 hasConceptScore W1948169006C526171541 @default.
• W1948169006 hasConceptScore W1948169006C62231903 @default.
• W1948169006 hasConceptScore W1948169006C71924100 @default.
• W1948169006 hasConceptScore W1948169006C89560881 @default.
• W1948169006 hasConceptScore W1948169006C98274493 @default.
• W1948169006 hasIssue "5" @default.
• W1948169006 hasLocation W19481690061 @default.
• W1948169006 hasLocation W19481690062 @default.
• W1948169006 hasOpenAccess W1948169006 @default.
• W1948169006 hasPrimaryLocation W19481690061 @default.

• next